The main aim of the current study was to summarize the findings of available clinical studies
to assess nano‐curcumin's influence on COVID patients. A comprehensive online search …

Background. Curcumin is a polyphenol derivative of the Curcuma longa rhizome, with
potential antioxidant, anticancer, antidepressant, antiviral, and anti‐inflammatory effects …

Different immunomodulation strategies have been used to manage COVID‐19 due to the
complex immune‐inflammatory processes involved in the pathogenesis of this infection …

It has been more than a year since the outbreak of COVID‐19, and it is still the most critical
issue of the healthcare system. Discovering effective strategies to treat infected patients is …

Curcumin is proposed as a potential treatment option for coronavirus disease‐19 (COVID‐
19) by inhibiting the virus entrance, encapsulation and replication, and modulating various …

The present study conducted a placebo‐controlled clinical trial to evaluate the impact of
nano‐curcumin on the inflammatory cytokines in mild‐to‐moderate hospitalized COVID‐19 …

Background Curcumin, a natural polyphenolic compound, is proposed as a potential
treatment option for patients with coronavirus disease by inhibiting the entry of virus to the …

Background As an ongoing worldwide health issue, Coronavirus disease 2019 (COVID–19)
has been causing serious complications, including pneumonia, acute respiratory distress …

Curcumin is a low‐cost and easily accessible therapeutic option for COVID‐19 patients. We
aimed to conduct a meta‐analysis to assess the effect of curcumin on clinical outcomes in …

Accumulating evidence has been reported regarding the effect of curcumin as a dietary
antiviral on patients with COVID-19; however, findings are controversial. Our systematic …